MosaiQ™ COVID-19 Antibody Microarray
Quotient response to COVID-19
MosaiQ COVID-19 Antibody Microarray
Learn more

Latest updates

index
News
Quotient Limited Added to the Russell 2000 and Russell 3000 Indexes

JERSEY, Channel Islands, July 01, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today announced that the Company has been added to the Russell 2000® and 3000® Indexes

Clyde News Pic
News
Clyde News: Visit to antibody testing facility

Scientists carrying out coronavirus antibody testing in Scotland are telling Clyde News we still don't have answers on the big question about immunity.

H2MosaiQ
News
Honeyman Group launches MosaiQ antibody testing platform for COVID-19

The Honeyman Group, a longstanding Quotient partner, today announced the launch of a new, highly sensitive antibody test utilizing the high-throughput MosaiQ™ platform which coupled with PCR screening can provide a systematic approach for businesses managing teams back-to-work”.

SRF microarray
News
SRF: Schweizer start-up zieht bei antikörpertests mit Roche gleich

Corona Antikörpertests rücken immer mehr in den Vordergrund. Gross in diesem Geschäft ist der Basler Pharma-Multi Roche. Neu auf dem Markt behauptet sich das Waadtländer Start-up Quotient.

STV
News
STV: What does getting a coronavirus antibody test involve?

On the 8th of June, reporter Gordon Chree from STV visited Quotient's Allan-Robb Campus in Penicuik, Scotland to interview Quotient Chief Operating Officer. While on site, he was also tested using the MosaiQ COVID-19 Antibody Microarray. 

The Sun Bellotti
News
The Sun: I took the antibody test that could help get millions back to work – by revealing they’ve had COVID WITHOUT realising

On the 6th of June 2020, The Sun journalist Alex Bellotti visited an hVIVO laboratory in East London to try out the newly launched “gold standard” coronavirus antibody test provided by Quotient using their MosaiQ technology.

View all
Who we are
The future made possible. Reshaping in vitro diagnostics.
Building on over 30 years of experience in transfusion diagnostics, we deliver game changing diagnostic solutions, empowering our customers to realize their full potential and improve their business.
Learn more
Investors
4:05 PM EDT • Jul 8, 2020
QTNT
7.54USD
-2.96%
Quotient Limited Added to the Russell 2000 and Russell 3000 Indexes
Read More
Quotient Limited Provides Update on COVID-19 Antibody Test Progress, Other Key Developments and Fourth Quarter and Full Year Fiscal 2020 Results
Read More
Quotient Limited to Participate in the Jefferies Virtual Healthcare Conference
Read More
Read all press releases
Careers
Careers
Help us achieve our mission to transform transfusion diagnostics and beyond
Joining Quotient is an opportunity to become part of a team that will shape the future of transfusion diagnostics
Learn more

Available positions

Job title
Department
Location
Quality Engineer
Quality Assurance
Eysins, Switzerland
Senior IT Business Analyst (Commercial Systems)
IT
Eysins, Switzerland
View all jobs
Reagents
Alba by Quotient. Experience. Expertise. Value.
These are just some of the qualities that set us apart from the competition. You can have peace of mind using our products, which have been time-tested for more than 30 years.
Learn more

Latest social posts